BMY Headlines | Bristol-Myers Squibb Company Co Stock - Yahoo! Finance

Dow

0.91% Nasdaq

0.87%

More On BMY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Bristol-Myers Squibb Company (BMY)

-NYSE

46.85 0.41(0.88%) 4:00PM EDT|After Hours : 46.85 0.00 (0.00%) 5:54PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Tuesday, June 18, 2013

Final Glance: Pharmaceuticals companiesAP (Tue 6:02PM EDT)
Midday Glance: Pharmaceuticals companiesAP (Tue 1:18PM EDT)
The Best Healthcare Betat Motley Fool (Tue 12:34PM EDT)
Early Glance: Pharmaceuticals companiesAP (Tue 10:21AM EDT)
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlementsat Forbes (Tue 10:13AM EDT)
Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based CareersBusiness Wire (Tue 9:00AM EDT)
Where Is Biotechnology's Next 'Anti-PD-1'?at Seeking Alpha (Tue 7:57AM EDT)
Arnold & Porter, Skadden, Cravath, Willkie: Business of Lawat Bloomberg (Tue 12:01AM EDT)

Monday, June 17, 2013

Drugmakers Opened to ‘Pay for Delay’ Suits by High Courtat Bloomberg (Mon, Jun 17)
Simcere Ties Up with Bristol-MyersZacks (Mon, Jun 17)
Can Cempra Beat The Superbugs?at Seeking Alpha (Mon, Jun 17)
J&J: Adding Another Pearl to its Acquisition Necklaceat Wall St. Cheat Sheet (Mon, Jun 17)
Data on BMY/ AbbVie's elotuzumabZacks (Mon, Jun 17)
Cramer: A 'Nightmare Scenario' for Bulls and Bearsat CNBC (Mon, Jun 17)
Gilead's Potential Megablockbuster Raises the Barat Motley Fool (Mon, Jun 17)
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?at Forbes (Mon, Jun 17)
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira PharmaceuticalsPR Newswire (Mon, Jun 17)
InPlay: Bristol-Myers and AbbVie (ABBV) reports progression-free survival data from Phase 2 open-label study of Elotuzumab in combination with Lenalidimide and Dexamethasone in previously-treated multiple myelomaBriefing.com (Mon, Jun 17)

Sunday, June 16, 2013

UK scientists win funding for new kind of anticoagulant drugat Reuters (Sun, Jun 16)
White Collar Criminals Love Biotech Stocksat Motley Fool (Sun, Jun 16)

Older Headlines

Add BMY News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.